Article Versions Notes

Wang H-C, Gao AC, Xia R, Wu C-T, Hsu S-W, Chen C-H, Shih T-C. Inhibition of Galectin-1 and Androgen Receptor Axis Enhances Enzalutamide Treatment in Enzalutamide Resistant Prostate Cancer. Cancers. 2025; 17(3):351. https://doi.org/10.3390/cancers17030351

Wang, Hsiao-Chi, Allen C. Gao, Roger Xia, Chun-Te Wu, Ssu-Wei Hsu, Ching-Hsien Chen, and Tsung-Chieh Shih. 2025. "Inhibition of Galectin-1 and Androgen Receptor Axis Enhances Enzalutamide Treatment in Enzalutamide Resistant Prostate Cancer" Cancers 17, no. 3: 351. https://doi.org/10.3390/cancers17030351

Wang, H.-C., Gao, A. C., Xia, R., Wu, C.-T., Hsu, S.-W., Chen, C.-H., & Shih, T.-C. (2025). Inhibition of Galectin-1 and Androgen Receptor Axis Enhances Enzalutamide Treatment in Enzalutamide Resistant Prostate Cancer. Cancers, 17(3), 351. https://doi.org/10.3390/cancers17030351